Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00112177Phase 3Completed
A Phase 3 trial of mosapride in functional dyspepsia (FD), sponsored by Forest Laboratories. Started Jul 2004; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00112177.